SPR Therapeutics
-
Devices & Diagnostics, Startups
FDA gives nod to first fully-removable percutaneous peripheral nerve stimulation device
SPR Therapeutics has developed a peripheral nerve stimulation system that is placed percutaneously through the skin instead of being implanted and which can be completely removed from the body after therapy period.
-
Devices & Diagnostics, Startups
Neurostimulation device firm SPR Therapeutics expands series A to $5M, awaits CE Mark
Cleveland-based medical device company SPR Therapeutics has upped its series A yet again and […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Devices & Diagnostics, Startups
SPR Therapeutics OK’ed for pivotal trial of device to treat post-stroke shoulder pain
A minimally invasive device to relieve shoulder pain after stroke is heading to phase 3 […]
-
Pain-relief neurostimulation company SPR gets $900K Ohio loan
Neurostimulation pain-relief device company SPR Therapeutics has been approved for a $900,000 loan from the […]
-
Pain relief device company raises $2.2M, eyes strategic partners
Neurostimulation pain-relief device company SPR Therapeutics has raised its series A round of investment to […]
-
SPR Therapeutics implants shoulder-pain device in first stroke patient
Neurostimulation startup SPR Therapeutics has reached an important milestone, implanting its post-stroke shoulder-pain device in […]
-
Pain-relief device startup SPR Therapeutics ups series A to $1M
Neurotechnology pain-relief device company SPR Therapeutics has increased its series A round of investment to […]
-
Neurotech firm SPR Therapeutics gets $250K JumpStart investment
Neurostimulation company SPR Therapeutics has received a $250,000 investment from JumpStart to help develop and […]
-
Neurotech startup SPR Therapeutics readies for launch of pain relief device
Assuming all goes well in a federal regulatory review, neurotechnology startup SPR Therapeutics expects to […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
A look at Northeast Ohio’s growing neurotechnology industry
Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company’s recent $78 million sale to Boston Scientific (NYSE: BSX) highlights Northeast Ohio’s growing strength in neurotechnology. Here’s a brief overview of the key players in Northeast Ohio’s rising neurotechnology industry.
-
Biomedical engineer knows her technology and her business
Maria Bennett has never been your generic biomedical engineer. Now, she’s also the chief executive of a company working to develop and market a neurostimulation device aimed at alleviating shoulder pain for stroke patients.
-
NDI Medical raises $4 million to incubate more neuromodulation technologies
NDI Medical LLC has raised $2.1 million to continue developing nerve-stimulating devices to answer patient needs and improve their health care. The Highland Hills company recently spun out two technologies — one identifies nerves and muscles during surgery; the other stimulates nerves to relieve chronic pain.